Act4 Biosimilars Action Plan
To speed up patient access to Biosimilar medications, Sandoz announces the Act4 Biosimilars Action Plan
SG Tylor
Source – Novartis On June 15, a global plan to improve patient access to biologic medicines was launched, according to ...
